- Home
- PULM vs BODI Comparison
PULM vs BODI Comparison
Compare PULM & BODI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- BODI
- Stock Information
- Founded
- PULM 2003
- BODI 1998
- Country
- PULM United States
- BODI United States
- Employees
- PULM N/A
- BODI N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- BODI Industrial Machinery/Components
- Sector
- PULM Health Care
- BODI Industrials
- Exchange
- PULM Nasdaq
- BODI Nasdaq
- Market Cap
- PULM 33.2M
- BODI 25.4M
- IPO Year
- PULM N/A
- BODI N/A
- Fundamental
- Price
- PULM $6.41
- BODI $3.99
- Analyst Decision
- PULM
- BODI Strong Buy
- Analyst Count
- PULM 0
- BODI 3
- Target Price
- PULM N/A
- BODI $10.67
- AVG Volume (30 Days)
- PULM 57.7K
- BODI 18.9K
- Earning Date
- PULM 08-12-2025
- BODI 08-05-2025
- Dividend Yield
- PULM N/A
- BODI N/A
- EPS Growth
- PULM N/A
- BODI N/A
- EPS
- PULM N/A
- BODI N/A
- Revenue
- PULM $1,921,000.00
- BODI $371,113,000.00
- Revenue This Year
- PULM N/A
- BODI N/A
- Revenue Next Year
- PULM $134.88
- BODI N/A
- P/E Ratio
- PULM N/A
- BODI N/A
- Revenue Growth
- PULM N/A
- BODI N/A
- 52 Week Low
- PULM $1.78
- BODI $3.38
- 52 Week High
- PULM $10.40
- BODI $8.71
- Technical
- Relative Strength Index (RSI)
- PULM 37.18
- BODI 48.88
- Support Level
- PULM $6.28
- BODI $3.81
- Resistance Level
- PULM $6.83
- BODI $4.15
- Average True Range (ATR)
- PULM 0.35
- BODI 0.28
- MACD
- PULM -0.07
- BODI 0.01
- Stochastic Oscillator
- PULM 0.00
- BODI 41.25
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About BODI The Beachbody Company Inc. Class A Common Stock
The Beachbody Co Inc is a health and wellness platform providing fitness, nutrition and stress-reducing programs to its customers. The product offerings of the company include Digital Subscriptions, Nutritional Products, and Connected Fitness Products. It earns the majority of its revenue from the United States. The company operates and manages its business in one operating segment. Majority of revenue is through Digital.